BGMD

BG Medicine Announces Obtaining CE Mark and Launching of Automated BGM Galectin-3 Test

[at noodls] – WALTHAM, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboardSee who BG is hiring next, click here to view […]

BG Medicine, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference

[at noodls] – WALTHAM, Mass., Nov. 20, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine Reports Third Quarter 2012 Financial Results and Provides Business Update

[at noodls] – WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD) today reported financial results for the third quarter ended September 30, 2012 and provided a business update. Total revenue … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine Outlines New Commercial Strategy

[at noodls] – WALTHAM, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today provided an update … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference

[at noodls] – WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

[at noodls] – WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that results … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine to Announce Third Quarter 2012 Earnings Results and Commercial Strategy Update and Host Conference Call on Tuesday, November 13, 2012

[at noodls] – WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Tuesday, November 13 at 8:00 a.m. Eastern Time … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]

BG Medicine Announces Decision by American Medical Association and Centers for Medicare and Medicaid Services on Analyte-Specific CPT(R) Code and Reimbursement for BGM Galectin-3(R) Test

[at noodls] – WALTHAM, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that the … moreView todays social media effects on BGMDView the latest stocks trending across Twitter. Click to view dashboard […]